Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trial

BACKGROUND: The goal of this prospective multicentric trial was to validate a technique that allowed for MGMT promoter methylation analysis in routine clinical practice. METHODS: The MGMT status of 139 glioblastoma patients, whom had received standard first line treatment, was determined using pyros...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncotarget
Главные авторы: Quillien, Véronique, Lavenu, Audrey, Ducray, François, Joly, Marie-Odile, Chinot, Olivier, Fina, Frédéric, Sanson, Marc, Carpentier, Catherine, Karayan-Tapon, Lucie, Rivet, Pierre, Entz-Werle, Natacha, Legrain, Michèle, Zalcman, Emmanuèle Lechapt, Levallet, Guenaelle, Escande, Fabienne, Ramirez, Carole, Chiforeanu, Dan, Vauleon, Elodie, Figarella-Branger, Dominique
Формат: Artigo
Язык:Inglês
Опубликовано: Impact Journals LLC 2016
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5308700/
https://ncbi.nlm.nih.gov/pubmed/27542245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11322
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы